Stopping GLP-1 Medications: What Happens to Your Weight

You have reached your goal weight. The active weight loss phase is done. Now comes the question that matters most: what do you do next?

Maybe you are thinking about stopping your medication entirely. Maybe you have already stopped and are watching the weight creep back up. Or maybe you are trying to decide whether to stay on something long-term, even at a lower dose.

The good news is that there is actual research data that can help you think through this decision clearly. The bad news is that the data is straightforward, and it might not be what you hoped to hear. But understanding it now, before you make a decision, is much better than learning it later.

What the STEP 4 trial showed: the most important data

In 2021, researchers published the results of a major clinical trial that tested exactly what happens when you stop GLP-1 medication. This trial, called STEP 4^[1], is the most directly relevant evidence we have for this decision.

Here is what they did: 902 patients who had successfully lost weight on semaglutide prescribed for weight management for 20 weeks were randomized into two groups. One group continued taking semaglutide at the full therapeutic dose (2.4mg per week). The other group switched to placebo, which meant they were stopping the medication, though they didn’t know which group they were in. They followed these patients for 48 weeks.

The results were clear.

At the 20-week mark, before randomization, both groups had lost approximately 10.6% of their starting body weight. After the following year of either continuing medication or being on placebo, here is what happened:

The group that continued semaglutide maintained their weight loss and continued losing weight. By the end of the study, they had achieved a net loss of approximately 17% from their baseline weight. They kept the results they had earned.

The group that switched to placebo regained weight steadily over the year. By the end, they had regained approximately two-thirds of the weight they had lost. It was not complete regain, but the trajectory was unmistakable: the appetite returned, the weight came back.

This is the single most important data point in any conversation about stopping GLP-1 medication. It is not theoretical. It is not anecdotal. It is the result of a well-designed clinical trial in a major medical journal.

Why regain happens: the biology

Now that you know what happens, let’s understand why it happens. This matters because it changes how you think about the situation.

GLP-1 is a naturally occurring hormone your body produces when you eat. It does several important things: it tells your brain that you are full, it slows how fast food moves through your stomach, and it reduces the mental urge to eat. It is one of several biological signals that regulate appetite.

For many people with obesity or overweight, this appetite-signaling system is dysregulated. The hormone is not working efficiently. The brain is not receiving the fullness signals it should. The constant urge to eat is louder than it should be. This is not a character flaw or a willpower issue. It is biology. It is called appetite dysregulation, and it is well-documented in medical research.

GLP-1 medications like semaglutide amplify this signal. They turn up the volume on the “I am full” message. They make the appetite urge quieter. They restore some fairness to a system that was already broken.

When you stop the medication, that amplification disappears. The volume returns to its normal setting, which for many people, is still dysregulated. The appetite signals that the medication was suppressing come roaring back. You are not suddenly weak or unmotivated. The biological pressure is back.

Here is the important nuance: patients who built strong dietary habits and exercise routines during treatment, and who actively practiced nutrition skills and movement, tend to do better after stopping than those who relied on medication alone. The lifestyle foundation matters. But research shows this benefit is modest. The STEP 4 data includes patients with diet and exercise support, and they still regained significant weight. Biology is powerful.

Who does well after stopping

Not everyone regains weight after stopping. Some people do maintain their results without ongoing medication. Understanding who tends to fall into this group can help you assess your own likelihood.

Patients who built genuine dietary habit changes. If you spent your treatment phase learning to prioritize protein, reduce ultra-processed foods, and develop eating patterns that feel sustainable, you are in a better position than someone who relied primarily on medication suppression to control intake.

Patients who added regular resistance training and maintained it. People who built a movement practice during treatment, particularly strength training, tend to sustain better results because muscle tissue is metabolically active and helps maintain weight stability.

Patients whose starting BMI was in the lower range (27 to 30) tend to do better after stopping than those starting from a BMI of 35 or higher. Less severe initial appetite dysregulation means less severe return when the medication stops.

Patients who achieved goal weight and then gradually reduced their dose before stopping entirely tend to do better than those who stopped abruptly. A step-down allows your system to adapt more gently.

None of these factors guarantee success. But they shift your odds. If you recognize yourself in multiple bullet points, you are in a better position than someone who was primarily using medication to manage appetite without building these other supports.

Three paths forward after reaching goal weight

If you have reached goal weight, or are considering stopping, you have three main options to think through with your provider.

Path 1: Stop completely. This works for some people. The STEP 4 data tells us it does not work for most. If you choose this path, understand that weight regain is statistically likely. If it happens, recognize it is not failure. It is biology returning. Restarting treatment or transitioning to a maintenance dose are both options. Do not wait until all the weight is back before reaching out.

Path 2: Continue your current full-dose treatment. For some patients, particularly those with ongoing obesity-related health conditions, staying on the medication indefinitely is the right choice. This is between you and your provider. This context is different from the maintenance conversation.

Path 3: Transition to a lower maintenance dose. This is the middle path. You keep the appetite-signaling support that the medication provides, but at a lower dose and cost. Your provider determines the right dose based on your individual response and goals. This is what the Transformation Health Microdose program is designed for.

The Transformation Health Microdose program as an option

If you are interested in continuing medication at a lower dose, the Microdose program is designed for exactly this situation.

The program is $199 per month, all-inclusive: your compounded medication at your prescribed maintenance dose, provider check-ins to monitor your progress and adjust your dose as needed, lab work to ensure your health markers remain stable, and medical weight loss coaching to support habit maintenance. There are no hidden fees.

Who qualifies:

• Prior GLP-1 experience (you have completed at least one full cycle of treatment)
• Current BMI of 20 or higher
• Provider evaluation determines that medication is appropriate for you

How to get started:

1. Complete a free online assessment about your health history, prior treatment, and current situation.
2. An independent, licensed provider reviews your assessment and determines whether maintenance dosing is clinically appropriate for you.
3. If approved, you have a consultation (phone or video, depending on your state) to discuss your specific maintenance plan.
4. Your medication is prepared by a licensed US compounding pharmacy and shipped to your door.
5. Your provider checks in regularly to monitor your progress and adjust your dose if needed.

Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation before a prescription can be written.

What to do if you have already stopped and regain is happening

If you have already stopped your medication and are watching the weight come back, you are not alone. This is extremely common.

What you are experiencing is not a sign that you failed or that the medication failed. It is the return of biological appetite signaling that the medication was modulating. It is normal. It is predictable. And you have options.

The sooner you address it, the easier it is to manage. These are your paths forward:

Restart treatment. You can return to your previous dose and continue active weight loss. Discuss this with your provider. If the medication worked for you before, it can work again.

Transition to a maintenance dose. Even if you do not want to restart full-dose treatment, a lower maintenance dose might be enough to stabilize your weight and prevent further regain. This is less aggressive and less costly than active treatment, but it provides ongoing biological support.

Pursue a lifestyle-only approach with professional support. Some people choose not to continue medication. If this is your path, work with a coach or provider who can help you build the eating habits and movement practices that will sustain your results. Be realistic about your odds, but if this is what you want to do, professional support makes a difference.

Do not wait. The longer weight regain continues, the harder it becomes to address. If you reach out while you have lost 3 to 5 pounds post-stopping, stopping the regain at that point is easier than addressing it once you have lost half your results.

Should you taper off or stop abruptly?

A question that comes up frequently: if I am going to stop, should I taper down slowly or can I stop abruptly?

Unlike some medications, GLP-1 receptor agonists do not require a medical taper to discontinue safely. There are no withdrawal symptoms. Your body will not go through distress if you stop the next day.

That said, a gradual reduction can help you and your system adjust more gently. Instead of stopping at 2.4mg, you might step down to 1.0mg for a week or two, then 0.5mg, then stop. This gives your appetite signals time to readjust in stages rather than flooding back all at once. It is not medically necessary, but it can be psychologically and practically easier.

If you are considering stopping, discuss this with your provider. They can help you design a step-down plan if you want one, or confirm that stopping abruptly is fine for your situation.

Key takeaways

The research is clear. The STEP 4 trial showed that when you stop GLP-1 medication, appetite returns and weight regain is statistically likely for most people. This is not a failure of willpower. It is biology.

You have three realistic paths: stopping completely (with the understanding that regain is likely), continuing your current dose (appropriate for ongoing health conditions), or transitioning to a lower maintenance dose (the middle ground).

If you have already stopped and regain is happening, reach out. You have options, and the sooner you address it, the better.

Your provider is your partner in this decision. They know your health history, your response to medication, your goals, and your personal context. Use them. The goal is to find what works for your body and your life long-term, not to fit into any particular approach.

Citations

[1] Rubino DM, et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults.” JAMA 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/